Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.

BJU Int · 2022 · PMC9796546 · PMID 35488182

Europe PMC DOI

hedged sentence

0.8400

closest p · 16.8× alpha

0.8400

boldest claim

The sentences

did not reach statistical significanceP = 0.84not close (p > 0.1)

Worse EFS was observed for patients with regional/distant metastasis on PSMA‐PET who received SRT compared to those with negative/locally recurrent disease PSMA‐PET findings in the EAU high‐risk group (37% vs 71%; HR 3.1, 95% CI 1.6–6.1; P = 0.001) but did not reach statistical significance in the EAU low‐risk group (71% vs 87%; HR 2.3, 95% CI 0.3–16; P = 0.84).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.